Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells.
Meta-analysis of associations between MTHFR and GST polymorphisms and susceptibility to multiple sclerosis.
Intermediate uveitis and multiple sclerosis: to scan or not to scan.
Perforin-Positive Dendritic Cells Exhibit an Immuno-regulatory Role in Metabolic Syndrome and Autoimmunity.
Multiple sclerosis: Spinal cord MRI reveals progression-related MS pathology.
Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide.
The Olig family affects central nervous system development and disease.
How People with Multiple Sclerosis Rate Their Quality of Life: An EQ-5D Survey via the UK MS Register.
Can multiple sclerosis as a cognitive disorder influence patients' dreams?
Use of botulinum toxin in individuals with neurogenic detrusor overactivity: State of the art review.
Role of intravenous immunoglobulin in the treatment of acute relapses of neuromyelitis optica: experience in 10 patients.
Intrathecal, polyspecific antiviral immune response in oligoclonal band negative multiple sclerosis.
Adrenal disorders and the paediatric brain: pathophysiological considerations and clinical implications.
Retrograde degeneration of visual pathway: hemimacular thinning of retinal ganglion cell layer in progressive and active multiple sclerosis.
Natural Killer Cell Subsets in Cerebrospinal Fluid of Patients with Multiple Sclerosis.
Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS.
Label-free method for anti-glucopeptide antibody detection in Multiple Sclerosis.
Characteristics of patients seeking health information online via social health networks versus general Internet sites: a comparative study.
Recognising and diagnosing inflammatory brain disease.
Pituitary-ovary axis and ovarian reserve in fertile women with multiple sclerosis: A pilot study.
A case of tumor-like inflammatory demyelinating disease with progressive brain and spinal cord involvement.
Association between a Functional HLA-G 14-bp Insertion/deletion Polymorphism and Susceptibility to Autoimmune Diseases: A Meta-analysis.
Systematic review of the influence of spasticity on quality of life in adults with chronic neurological conditions.
Comparative Effectiveness Using A Matching-Adjusted Indirect Comparison Between Delayed-Release Dimethyl Fumarate and Fingolimod for The Treatment of Relapsing-Remitting Multiple Sclerosis.
Multiple sclerosis: Generic glatiramer acetate - a step toward cheaper MS drugs?
Pages
« first
‹ previous
…
415
416
417
418
419
420
421
422
423
…
next ›
last »